首页 > 最新文献

Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery最新文献

英文 中文
A case of lung adenocarcinoma developing chylothorax after transthoracic Tru-cut biopsy. 一例经胸 Tru 切片活检后出现乳糜胸的肺腺癌。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-11-06 eCollection Date: 2024-01-01 DOI: 10.5606/tgkdc.dergisi.2024.22556
Şerife Torun, Çağrı Kesim, Mehmet Dalokay Kılıç

Chylothoraces are mostly secondary to trauma and tumors, and rarely idiopathic. Chylothoraces secondary to lung tumors are mostly seen postoperatively. In this article, we, for the first time, present massive chylothorax developing after diagnostic transthoracic Tru-cut biopsy in a lung adenocarcinoma case. The patient was successfully treated with drainage and octreotide. In conclusion, it should be kept in mind that chylothorax can be also seen as a complication after interventional biopsy procedures; therefore, the patients should be followed carefully.

乳糜胸大多继发于外伤和肿瘤,很少是特发性的。继发于肺部肿瘤的乳糜胸多见于术后。在本文中,我们首次介绍了一例肺腺癌患者在经胸 Tru 切开活检诊断后出现的巨大乳糜胸。患者经引流和奥曲肽治疗后获得成功。总之,应当牢记的是,乳糜胸也可能是介入活检术后的并发症;因此,应当对患者进行仔细随访。
{"title":"A case of lung adenocarcinoma developing chylothorax after transthoracic Tru-cut biopsy.","authors":"Şerife Torun, Çağrı Kesim, Mehmet Dalokay Kılıç","doi":"10.5606/tgkdc.dergisi.2024.22556","DOIUrl":"10.5606/tgkdc.dergisi.2024.22556","url":null,"abstract":"<p><p>Chylothoraces are mostly secondary to trauma and tumors, and rarely idiopathic. Chylothoraces secondary to lung tumors are mostly seen postoperatively. In this article, we, for the first time, present massive chylothorax developing after diagnostic transthoracic Tru-cut biopsy in a lung adenocarcinoma case. The patient was successfully treated with drainage and octreotide. In conclusion, it should be kept in mind that chylothorax can be also seen as a complication after interventional biopsy procedures; therefore, the patients should be followed carefully.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"32 1","pages":"101-104"},"PeriodicalIF":0.6,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-bacterial thrombotic endocarditis in long-standing primary hypoparathyroidism: A case report. 长期原发性甲状旁腺功能减退症的非细菌性血栓性心内膜炎:病例报告
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2023-11-06 eCollection Date: 2024-07-01 DOI: 10.5606/tgkdc.dergisi.2024.24908
Tolga Eroğlu, Nevin Durdu, Gökhan Arslanhan, Şahin Şenay, Cem Alhan

Non-bacterial thrombotic endocarditis is a rare condition characterized by the formation of thrombotic vegetations on heart valve leaflets, leading to valvular dysfunction, heart failure and thromboembolic events. It is known to be associated with other diseases and some cases remain undiagnosed or can be diagnosed in the postmortem analysis. Surgical excision of the mass may be necessary to prevent further embolic events and other complications. In this article, we report a young patient with non-bacterial thrombotic endocarditis, whose medical history was significant for primary hypoparathyroidism and a positive family history of coagulation disorders.

非细菌性血栓性心内膜炎是一种罕见的疾病,其特点是在心脏瓣膜叶上形成血栓性植被,导致瓣膜功能障碍、心力衰竭和血栓栓塞事件。众所周知,它与其他疾病相关,有些病例仍未确诊,或可在尸检时确诊。为防止进一步的栓塞事件和其他并发症,手术切除肿块可能是必要的。在本文中,我们报告了一名患有非细菌性血栓性心内膜炎的年轻患者,其病史中有原发性甲状旁腺功能减退症和凝血功能障碍阳性家族史。
{"title":"Non-bacterial thrombotic endocarditis in long-standing primary hypoparathyroidism: A case report.","authors":"Tolga Eroğlu, Nevin Durdu, Gökhan Arslanhan, Şahin Şenay, Cem Alhan","doi":"10.5606/tgkdc.dergisi.2024.24908","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2024.24908","url":null,"abstract":"<p><p>Non-bacterial thrombotic endocarditis is a rare condition characterized by the formation of thrombotic vegetations on heart valve leaflets, leading to valvular dysfunction, heart failure and thromboembolic events. It is known to be associated with other diseases and some cases remain undiagnosed or can be diagnosed in the postmortem analysis. Surgical excision of the mass may be necessary to prevent further embolic events and other complications. In this article, we report a young patient with non-bacterial thrombotic endocarditis, whose medical history was significant for primary hypoparathyroidism and a positive family history of coagulation disorders.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"32 3","pages":"333-336"},"PeriodicalIF":0.5,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of cardiac surgery on survival in patients with trisomy 18: A single-center experience. 心脏手术对 18 三体综合征患者存活率的影响:单中心经验。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.24741
Mehmet Çelik, Mahmut Gökdemir, Nimet Cındık, Asım Çağrı Günaydın

Background: In this study, we aimed to compare the results of operated patients diagnosed with trisomy 18 with those who were followed with medical treatment alone.

Methods: Between May 2014 and January 2022, a total of 18 patients (6 males, 12 females; median age: 39 days; range, 32 to 79 days) diagnosed with trisomy 18 were retrospectively analyzed. Patient data were obtained from the pediatric cardiovascular surgery digital database. The patients were divided into two groups: those who underwent surgery (n=10) and those who were followed with medical treatment (n=8).

Results: Cardiac pathology was detected in all 18 patients included in the study. Three (30%) patients in the surgical group and two (25%) patients in the medical treatment group were discharged and followed with medical treatment. One of the three patients discharged after surgery died during follow-up. The median survival in surgical and medical treatment groups was 150 (range, 75 to 308) days and eight (range, 3 to 51) days, respectively (p=0.009). While patients in the medical treatment group died due to multi-organ failure, those in surgical group died due to sepsis, heart failure, and respiratory failure.

Conclusion: Although cardiac surgery contributed positively to survival in patients with trisomy 18, the mortality rate was still high due to non-cardiac causes. We believe that a multidisciplinary approach would contribute positively to the treatment of this patient group with multi-organ failure and would aid in prolonging their life span.

背景:本研究旨在比较确诊为 18 三体综合征的手术患者与单纯药物治疗患者的治疗效果:在这项研究中,我们旨在比较确诊为18三体综合征的手术患者与仅接受药物治疗的患者的结果:方法:对2014年5月至2022年1月期间确诊为18三体综合征的18例患者(男6例,女12例;中位年龄:39天;范围:32至79天)进行回顾性分析。患者数据来自儿科心血管外科数字数据库。患者分为两组:接受手术治疗的患者(10 人)和接受药物治疗的患者(8 人):结果:研究中的 18 名患者均发现了心脏病变。手术组和药物治疗组分别有 3 名(30%)和 2 名(25%)患者出院并接受药物治疗。手术后出院的三名患者中有一人在随访期间死亡。手术组和药物治疗组的中位生存期分别为 150 天(范围为 75 至 308 天)和 8 天(范围为 3 至 51 天)(P=0.009)。内科治疗组患者死于多器官衰竭,而外科治疗组患者死于败血症、心力衰竭和呼吸衰竭:结论:虽然心脏手术对 18 三体综合征患者的存活率有积极作用,但非心脏原因导致的死亡率仍然很高。我们相信,多学科方法将对治疗这类多器官功能衰竭患者起到积极作用,并有助于延长他们的寿命。
{"title":"Effect of cardiac surgery on survival in patients with trisomy 18: A single-center experience.","authors":"Mehmet Çelik, Mahmut Gökdemir, Nimet Cındık, Asım Çağrı Günaydın","doi":"10.5606/tgkdc.dergisi.2023.24741","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.24741","url":null,"abstract":"<p><strong>Background: </strong>In this study, we aimed to compare the results of operated patients diagnosed with trisomy 18 with those who were followed with medical treatment alone.</p><p><strong>Methods: </strong>Between May 2014 and January 2022, a total of 18 patients (6 males, 12 females; median age: 39 days; range, 32 to 79 days) diagnosed with trisomy 18 were retrospectively analyzed. Patient data were obtained from the pediatric cardiovascular surgery digital database. The patients were divided into two groups: those who underwent surgery (n=10) and those who were followed with medical treatment (n=8).</p><p><strong>Results: </strong>Cardiac pathology was detected in all 18 patients included in the study. Three (30%) patients in the surgical group and two (25%) patients in the medical treatment group were discharged and followed with medical treatment. One of the three patients discharged after surgery died during follow-up. The median survival in surgical and medical treatment groups was 150 (range, 75 to 308) days and eight (range, 3 to 51) days, respectively (p=0.009). While patients in the medical treatment group died due to multi-organ failure, those in surgical group died due to sepsis, heart failure, and respiratory failure.</p><p><strong>Conclusion: </strong>Although cardiac surgery contributed positively to survival in patients with trisomy 18, the mortality rate was still high due to non-cardiac causes. We believe that a multidisciplinary approach would contribute positively to the treatment of this patient group with multi-organ failure and would aid in prolonging their life span.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"440-445"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative risk factors of airway complications in adult lung transplant recipients: A systematic review and meta-analysis. 成人肺移植受者气道并发症的术前风险因素:系统回顾和荟萃分析。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.25399
Mahmut Subasi, Mustafa Duger

Background: In this systematic review and meta-analysis, we aimed to identify recipient-related preoperative risk factors for airway complications following lung transplantation in adults.

Methods: Articles published between November 1995 and February 2023 were searched by a thorough exploration of databases. Studies that addressed recipient-related risk factors for airway complications following adult lung transplantation, such as cohorts, case-control, or cross-sectional studies, were included. Fixed-effects or random-effects models were used to calculate the odds ratios (ORs) or mean differences (MDs) with 95% confidence interval (CI).

Results: Twenty-one studies including a total of 38,321 recipients fulfilled the inclusion criteria. Based on the pooled analyses, taller height (MD=5.98, 95% CI: 5.69-6.27, I2=57.32%), intraoperative mechanical ventilation (OR=1.83, 95% CI: 1.41-2.38, I2=0%), male sex (OR=1.52, 95% CI: 1.33-1.74, I2 =15.91%), preoperative extracorporeal membrane oxygenation (OR=1.58, 95% CI: 1.1-2.26, I2=41.47%), and preoperative steroid use (OR=1.21, 95% CI: 1.04-1.41, I2=0%) elevated the risk of airway complications following lung transplantation.

Conclusion: Taller height, intraoperative mechanical ventilation, male sex, preoperative extracorporeal membrane oxygenation, and preoperative steroid use can increase the risk of airway complications after lung transplantation. Identifying high-risk recipients or riskless situations can support the advancement of selective treatments or prevent the unnecessary avoidance of certain interventions.

背景在这篇系统综述和荟萃分析中,我们旨在确定成人肺移植术后气道并发症的受者相关术前风险因素:方法:通过对数据库的全面检索,我们对 1995 年 11 月至 2023 年 2 月间发表的文章进行了检索。纳入了针对成人肺移植术后气道并发症受者相关风险因素的研究,如队列、病例对照或横断面研究。采用固定效应或随机效应模型计算几率比(ORs)或平均差(MDs)及95%置信区间(CI):共有 21 项研究符合纳入标准,研究对象共计 38,321 人。根据汇总分析,身高(MD=5.98,95% CI:5.69-6.27,I2=57.32%)、术中机械通气(OR=1.83,95% CI:1.41-2.38,I2=0%)、男性(OR=1.52,95% CI:1.33-1.74,I2=15.91%)、术前体外膜氧合(OR=1.58,95% CI:1.1-2.26,I2=41.47%)和术前使用类固醇(OR=1.21,95% CI:1.04-1.41,I2=0%)会增加肺移植术后气道并发症的风险:结论:身高、术中机械通气、男性、术前体外膜肺氧合和术前使用类固醇会增加肺移植术后气道并发症的风险。识别高风险受者或无风险情况有助于推进选择性治疗或防止不必要地避免某些干预措施。
{"title":"Preoperative risk factors of airway complications in adult lung transplant recipients: A systematic review and meta-analysis.","authors":"Mahmut Subasi, Mustafa Duger","doi":"10.5606/tgkdc.dergisi.2023.25399","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.25399","url":null,"abstract":"<p><strong>Background: </strong>In this systematic review and meta-analysis, we aimed to identify recipient-related preoperative risk factors for airway complications following lung transplantation in adults.</p><p><strong>Methods: </strong>Articles published between November 1995 and February 2023 were searched by a thorough exploration of databases. Studies that addressed recipient-related risk factors for airway complications following adult lung transplantation, such as cohorts, case-control, or cross-sectional studies, were included. Fixed-effects or random-effects models were used to calculate the odds ratios (ORs) or mean differences (MDs) with 95% confidence interval (CI).</p><p><strong>Results: </strong>Twenty-one studies including a total of 38,321 recipients fulfilled the inclusion criteria. Based on the pooled analyses, taller height (MD=5.98, 95% CI: 5.69-6.27, <i>I<sup>2</sup></i>=57.32%), intraoperative mechanical ventilation (OR=1.83, 95% CI: 1.41-2.38, <i>I<sup>2</sup></i>=0%), male sex (OR=1.52, 95% CI: 1.33-1.74, <i>I<sup>2</sup></i> =15.91%), preoperative extracorporeal membrane oxygenation (OR=1.58, 95% CI: 1.1-2.26, <i>I<sup>2</sup></i>=41.47%), and preoperative steroid use (OR=1.21, 95% CI: 1.04-1.41, <i>I<sup>2</sup></i>=0%) elevated the risk of airway complications following lung transplantation.</p><p><strong>Conclusion: </strong>Taller height, intraoperative mechanical ventilation, male sex, preoperative extracorporeal membrane oxygenation, and preoperative steroid use can increase the risk of airway complications after lung transplantation. Identifying high-risk recipients or riskless situations can support the advancement of selective treatments or prevent the unnecessary avoidance of certain interventions.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"517-529"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of CHA2DS2-VASc score for the long-term cardiovascular events after coronary artery bypass grafting. CHA2DS2-VASc 评分对冠状动脉旁路移植术后长期心血管事件的预后价值。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.24964.
Abdulkadir Ercan, Orcun Gurbuz, Zekeriya Afsin Culhaoglu, Gencehan Kumtepe, Hakan Ozkan, Ahmet Yuksel, Serdar Ener

Background: This study aims to investigate the value of the CHA2DS2-VASc score in predicting long-term major cardiovascular events following coronary artery bypass grafting.

Methods: Between January 2008 and January 2010, a total of 559 patients (445 males, 114 females; mean age: 62.7±9.1 years; range, 35 to 84 years) who underwent elective coronary artery bypass grafting were retrospectively analyzed. At a mean of 10.7±3.1-year follow-up, major cardiovascular events were considered as the primary endpoint.

Results: The multivariate Cox hazard analysis identified the CHA2DS2-VASc score as an independent predictor of major cardiovascular events (hazard ratio: 1.615; 95% confidence interval: 1.038-2.511; p=0.034). The receiver operating characteristic curve analyses revealed that 3.5 was the most optimal cut-off value of the score predicting major cardiovascular events and the patients were divided into two groups accordingly. The Kaplan-Meier analysis demonstrated a significantly higher incidence of major cardiovascular events in proportion to a higher CHA2DS2-VASc score (p<0.001).

Conclusion: CHA2DS2-VASc score ≥4, which includes many risk factors for cardiovascular events, can be used as an independent predictor of long-term major cardiovascular events after coronary artery bypass grafting.

背景本研究旨在探讨CHA2DS2-VASc评分在预测冠状动脉旁路移植术后长期主要心血管事件方面的价值:方法: 对 2008 年 1 月至 2010 年 1 月期间接受择期冠状动脉搭桥术的 559 例患者(男性 445 例,女性 114 例;平均年龄:62.7±9.1 岁;年龄范围:35 岁至 84 岁)进行回顾性分析。在平均 10.7±3.1 年的随访中,主要心血管事件被视为主要终点:多变量 Cox 危险分析确定 CHA2DS2-VASc 评分是重大心血管事件的独立预测因子(危险比:1.615;95% 置信区间:1.038-2.511;P=0.034)。接收器操作特征曲线分析表明,3.5 是预测重大心血管事件的最佳分界值,并据此将患者分为两组。Kaplan-Meier 分析表明,CHA2DS2-VASc 评分越高,重大心血管事件的发生率越高(p 结论:CHA2DS2-VASc 评分越高,重大心血管事件的发生率越高:CHA2DS2-VASc评分≥4分包含了许多心血管事件的危险因素,可作为冠状动脉旁路移植术后长期主要心血管事件的独立预测指标。
{"title":"Prognostic value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score for the long-term cardiovascular events after coronary artery bypass grafting.","authors":"Abdulkadir Ercan, Orcun Gurbuz, Zekeriya Afsin Culhaoglu, Gencehan Kumtepe, Hakan Ozkan, Ahmet Yuksel, Serdar Ener","doi":"10.5606/tgkdc.dergisi.2023.24964.","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.24964.","url":null,"abstract":"<p><strong>Background: </strong>This study aims to investigate the value of the CHA2DS2-VASc score in predicting long-term major cardiovascular events following coronary artery bypass grafting.</p><p><strong>Methods: </strong>Between January 2008 and January 2010, a total of 559 patients (445 males, 114 females; mean age: 62.7±9.1 years; range, 35 to 84 years) who underwent elective coronary artery bypass grafting were retrospectively analyzed. At a mean of 10.7±3.1-year follow-up, major cardiovascular events were considered as the primary endpoint.</p><p><strong>Results: </strong>The multivariate Cox hazard analysis identified the CHA<sub>2</sub>DS<sub>2</sub>-VASc score as an independent predictor of major cardiovascular events (hazard ratio: 1.615; 95% confidence interval: 1.038-2.511; p=0.034). The receiver operating characteristic curve analyses revealed that 3.5 was the most optimal cut-off value of the score predicting major cardiovascular events and the patients were divided into two groups accordingly. The Kaplan-Meier analysis demonstrated a significantly higher incidence of major cardiovascular events in proportion to a higher CHA<sub>2</sub>DS<sub>2</sub>-VASc score (p<0.001).</p><p><strong>Conclusion: </strong>CHA<sub>2</sub>DS<sub>2</sub>-VASc score ≥4, which includes many risk factors for cardiovascular events, can be used as an independent predictor of long-term major cardiovascular events after coronary artery bypass grafting.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"479-488"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended resections in the treatment of locally advanced lung cancer. 局部晚期肺癌治疗中的扩大切除术。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.24788
Ömer Topaloğlu, Atila Türkyılmaz, Sami Karapolat, Alaaddin Buran, Celal Tekinbaş

Background: This study aims to evaluate surgical outcomes and prognosis in patients who underwent extended lung resection for locally advanced lung cancer.

Methods: Between January 2015 and December 2019, a total of 61 patients (60 males, 1 female; mean age: 61.7±12.2 years; range, 32 to 90 years) with locally advanced non-small-cell lung cancer who underwent extended lung resection were retrospectively analyzed. Data including age, sex, comorbid diseases, symptoms, smoking status, pulmonary function test results, tumor location, methods used for preoperative tissue diagnosis, histopathological cell type, type of surgical resection, pathological stage, nodal involvement, postoperative complications, types of adjuvant therapy, and mortality rate were recorded. Survival and the factors affecting survival were examined.

Results: Seven (11.4%) patients had Stage IIIB, 40 (65.5%) patients had Stage IIIA, and 14 (22.9%) patients had Stage IB disease. Intrapericardial pneumonectomy accounted for 30 (49.1%) of all extended lung resections. Chemotherapy was administered to 31 (50.8%) patients and chemoradiotherapy to 24 (39.3%) patients in the postoperative period. In the survival analysis, 70-month survival rate was calculated as 63.9% and the median survival was 48 months. There was a statistically significant association between survival with adjuvant chemotherapy and chemoradiotherapy (p=0.003). The mortality rate at 70 months of follow-up was 36.1%.

Conclusion: Extended lung resection contributes significantly to the improvement of survival rates in carefully selected locally advanced cases. Particularly with adjuvant chemotherapy, local recurrences can be prevented, and survival rates can be improved.

背景:本研究旨在评估局部晚期肺癌扩大肺切除术患者的手术效果和预后:本研究旨在评估因局部晚期肺癌而接受扩大肺切除术的患者的手术效果和预后:回顾性分析2015年1月至2019年12月期间接受扩大肺切除术的61例局部晚期非小细胞肺癌患者(男60例,女1例;平均年龄:61.7±12.2岁;范围:32至90岁)。记录的数据包括年龄、性别、合并症、症状、吸烟状况、肺功能测试结果、肿瘤位置、术前组织诊断方法、组织病理学细胞类型、手术切除类型、病理分期、结节受累情况、术后并发症、辅助治疗类型和死亡率。结果显示,有 7 例(11.4%)患者在术后出现并发症:7例(11.4%)患者为IIIB期,40例(65.5%)患者为IIIA期,14例(22.9%)患者为IB期。在所有扩大肺切除术中,有30例(49.1%)进行了心包内肺切除术。31例(50.8%)患者接受了化疗,24例(39.3%)患者在术后接受了化放疗。在生存分析中,70 个月生存率为 63.9%,中位生存期为 48 个月。辅助化疗和化疗放疗与生存率之间有明显的统计学关系(P=0.003)。随访70个月的死亡率为36.1%:结论:对于精心挑选的局部晚期病例,扩大肺切除术对提高生存率有很大帮助。结论:对于经过慎重选择的局部晚期病例,扩大肺切除术对提高生存率有很大帮助,特别是通过辅助化疗,可以预防局部复发,提高生存率。
{"title":"Extended resections in the treatment of locally advanced lung cancer.","authors":"Ömer Topaloğlu, Atila Türkyılmaz, Sami Karapolat, Alaaddin Buran, Celal Tekinbaş","doi":"10.5606/tgkdc.dergisi.2023.24788","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.24788","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate surgical outcomes and prognosis in patients who underwent extended lung resection for locally advanced lung cancer.</p><p><strong>Methods: </strong>Between January 2015 and December 2019, a total of 61 patients (60 males, 1 female; mean age: 61.7±12.2 years; range, 32 to 90 years) with locally advanced non-small-cell lung cancer who underwent extended lung resection were retrospectively analyzed. Data including age, sex, comorbid diseases, symptoms, smoking status, pulmonary function test results, tumor location, methods used for preoperative tissue diagnosis, histopathological cell type, type of surgical resection, pathological stage, nodal involvement, postoperative complications, types of adjuvant therapy, and mortality rate were recorded. Survival and the factors affecting survival were examined.</p><p><strong>Results: </strong>Seven (11.4%) patients had Stage IIIB, 40 (65.5%) patients had Stage IIIA, and 14 (22.9%) patients had Stage IB disease. Intrapericardial pneumonectomy accounted for 30 (49.1%) of all extended lung resections. Chemotherapy was administered to 31 (50.8%) patients and chemoradiotherapy to 24 (39.3%) patients in the postoperative period. In the survival analysis, 70-month survival rate was calculated as 63.9% and the median survival was 48 months. There was a statistically significant association between survival with adjuvant chemotherapy and chemoradiotherapy (p=0.003). The mortality rate at 70 months of follow-up was 36.1%.</p><p><strong>Conclusion: </strong>Extended lung resection contributes significantly to the improvement of survival rates in carefully selected locally advanced cases. Particularly with adjuvant chemotherapy, local recurrences can be prevented, and survival rates can be improved.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"538-546"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic valve neocuspidization with the Ozaki procedure in congenital aortic valve disease: Early results. 在先天性主动脉瓣疾病中使用 Ozaki 手术进行主动脉瓣新瓣成形术:早期结果。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.25537
Murat Cicek, Fatih Ozdemir

Background: In this study, we present our early results with the Ozaki procedure in the treatment of congenital aortic valve disease. Methods: Between July 2021 and July 2023, a total of 14 patients (10 males, 4 females; median age: 13.9 years; range, 8.5 to 15 years) who underwent neoaortic valve reconstruction of three leaflets using Ozaki procedure were retrospectively analyzed. Preoperative, postoperative, and follow-up echocardiogram images were evaluated. Results: Preoperative indications were aortic regurgitation (n=3) or combined aortic stenosis and regurgitation (n=11). The median aortic annular diameter was 23 (range, 19.5 to 25) mm on preoperative echocardiography. The median preoperative peak systolic aortic valve gradient for patients with aortic stenosis was 60 (range, 45 to 93) mmHg. The median preoperative aortic valve regurgitation grade was 4 (range, 3 to 4). Autologous pericardium and bovine pericardium were used in 12 and two patients, respectively. There was no conversion to valve replacement, myocardial infarction, or mortality in the early postoperative period. The median follow-up time was 8.5 (range, 6 to 19) months. One patient who performed the Ozaki procedure with bovine pericardium underwent valve replacement eight months later. Conclusion: The Ozaki procedure can be performed safely and effectively in congenital aortic valve stenosis and insufficiency with promising early results.

背景:在本研究中,我们介绍了使用尾崎手术治疗先天性主动脉瓣疾病的早期结果。手术方法回顾性分析了 2021 年 7 月至 2023 年 7 月期间接受 Ozaki 手术重建三叶新主动脉瓣的 14 例患者(男 10 例,女 4 例;中位年龄:13.9 岁;范围:8.5 岁至 15 岁)。对术前、术后和随访超声心动图图像进行了评估。结果术前适应症为主动脉瓣反流(3 例)或合并主动脉瓣狭窄和反流(11 例)。术前超声心动图显示,主动脉瓣环直径中位数为 23 毫米(范围为 19.5 至 25 毫米)。主动脉瓣狭窄患者术前主动脉瓣收缩压峰值梯度的中位数为 60(范围为 45 至 93)mmHg。术前主动脉瓣反流等级的中位数为 4(范围为 3 至 4)。分别有 12 名和 2 名患者使用了自体心包和牛心包。术后早期没有患者转为瓣膜置换术、心肌梗死或死亡。中位随访时间为 8.5 个月(6 至 19 个月)。一名使用牛心包进行尾崎手术的患者在八个月后接受了瓣膜置换术。结论:对于先天性主动脉瓣狭窄和功能不全的患者,可以安全有效地实施尾崎手术,而且早期效果良好。
{"title":"Aortic valve neocuspidization with the Ozaki procedure in congenital aortic valve disease: Early results.","authors":"Murat Cicek, Fatih Ozdemir","doi":"10.5606/tgkdc.dergisi.2023.25537","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.25537","url":null,"abstract":"<p><p><b><i>Background:</i></b> In this study, we present our early results with the Ozaki procedure in the treatment of congenital aortic valve disease. <b><i>Methods:</i></b> Between July 2021 and July 2023, a total of 14 patients (10 males, 4 females; median age: 13.9 years; range, 8.5 to 15 years) who underwent neoaortic valve reconstruction of three leaflets using Ozaki procedure were retrospectively analyzed. Preoperative, postoperative, and follow-up echocardiogram images were evaluated. <b><i>Results:</i></b> Preoperative indications were aortic regurgitation (n=3) or combined aortic stenosis and regurgitation (n=11). The median aortic annular diameter was 23 (range, 19.5 to 25) mm on preoperative echocardiography. The median preoperative peak systolic aortic valve gradient for patients with aortic stenosis was 60 (range, 45 to 93) mmHg. The median preoperative aortic valve regurgitation grade was 4 (range, 3 to 4). Autologous pericardium and bovine pericardium were used in 12 and two patients, respectively. There was no conversion to valve replacement, myocardial infarction, or mortality in the early postoperative period. The median follow-up time was 8.5 (range, 6 to 19) months. One patient who performed the Ozaki procedure with bovine pericardium underwent valve replacement eight months later. <b><i>Conclusion:</i></b> The Ozaki procedure can be performed safely and effectively in congenital aortic valve stenosis and insufficiency with promising early results.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"431-439"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive versus conventional mitral valve surgery: A propensity score matching analysis. 微创与传统二尖瓣手术:倾向得分匹配分析
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.25404
Emre Yaşar, Zihni Mert Duman, Muhammed Bayram, Mete Gürsoy, Ersin Kadiroğulları, Ünal Aydın, Burak Onan

Background: This study aimed to compare the outcomes of minimally invasive mitral valve surgery and conventional surgery in terms of mortality and postoperative complications.

Methods: A retrospective analysis was conducted on consecutive minimally invasive and conventional mitral valve surgeries performed between January 2019 and December 2022. Patients undergoing concomitant procedures were excluded from the study, and 293 patients (149 females, 144 males; mean age: 53.8±12.9 years; range, 18 to 82 years) were included in the study. Of these patients, 96 underwent minimally invasive surgery (MI group), and 197 underwent mitral valve surgery via conventional sternotomy (CS group). Propensity score matching was utilized to minimize the biases and confounding factors. After propensity score matching, 55 patients were included in each group.

Results: There was no statistically significant difference in terms of mortality between the propensity score-matched groups (p=0.315), and no statistically significant difference in postoperative complications was observed between the groups. However, it was found that postoperative new-onset atrial fibrillation was lower in the minimally invasive group (p=0.022).

Conclusion: This study demonstrates that minimally invasive mitral valve surgery is a safe alternative with similar mortality and postoperative complication rates compared to conventional surgery. Additionally, the study suggests an association between minimally invasive surgery and postoperative new onset atrial fibrillation.

背景:本研究旨在比较微创二尖瓣手术和传统手术在死亡率和术后并发症方面的结果:本研究旨在比较微创二尖瓣手术和传统手术在死亡率和术后并发症方面的结果:对2019年1月至2022年12月期间连续进行的微创和传统二尖瓣手术进行了回顾性分析。研究排除了同时接受手术的患者,共纳入 293 例患者(女性 149 例,男性 144 例;平均年龄:53.8±12.9 岁;范围:18 至 82 岁)。在这些患者中,96人接受了微创手术(MI组),197人通过传统胸骨切开术接受了二尖瓣手术(CS组)。为减少偏差和混杂因素,研究采用了倾向评分匹配法。经过倾向评分匹配后,每组各有55名患者:结果:倾向评分匹配组与CS组在死亡率方面没有统计学差异(P=0.315),两组在术后并发症方面也没有统计学差异。但研究发现,微创组术后新发房颤的发生率较低(P=0.022):本研究表明,微创二尖瓣手术是一种安全的选择,死亡率和术后并发症发生率与传统手术相似。此外,该研究还表明微创手术与术后新发房颤之间存在关联。
{"title":"Minimally invasive versus conventional mitral valve surgery: A propensity score matching analysis.","authors":"Emre Yaşar, Zihni Mert Duman, Muhammed Bayram, Mete Gürsoy, Ersin Kadiroğulları, Ünal Aydın, Burak Onan","doi":"10.5606/tgkdc.dergisi.2023.25404","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.25404","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to compare the outcomes of minimally invasive mitral valve surgery and conventional surgery in terms of mortality and postoperative complications.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on consecutive minimally invasive and conventional mitral valve surgeries performed between January 2019 and December 2022. Patients undergoing concomitant procedures were excluded from the study, and 293 patients (149 females, 144 males; mean age: 53.8±12.9 years; range, 18 to 82 years) were included in the study. Of these patients, 96 underwent minimally invasive surgery (MI group), and 197 underwent mitral valve surgery via conventional sternotomy (CS group). Propensity score matching was utilized to minimize the biases and confounding factors. After propensity score matching, 55 patients were included in each group.</p><p><strong>Results: </strong>There was no statistically significant difference in terms of mortality between the propensity score-matched groups (p=0.315), and no statistically significant difference in postoperative complications was observed between the groups. However, it was found that postoperative new-onset atrial fibrillation was lower in the minimally invasive group (p=0.022).</p><p><strong>Conclusion: </strong>This study demonstrates that minimally invasive mitral valve surgery is a safe alternative with similar mortality and postoperative complication rates compared to conventional surgery. Additionally, the study suggests an association between minimally invasive surgery and postoperative new onset atrial fibrillation.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"498-506"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of kinesio taping on pain, respiratory function, and muscle strength after thoracotomy. 胸廓切开术后肌腱贴对疼痛、呼吸功能和肌肉力量的影响
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.24407
Neriman Temel Aksu, Mükerrem Erdoğan, Abdullah Erdoğan
Background This study aims to investigate the effectiveness of kinesio taping on pain, respiratory function, and respiratory muscle strength in patients after posterolateral thoracotomy. Methods Between June 2019 and May 2020, a total of 88 patients (48 males, 40 females; mean age: 56.1±9.0 years; range, 28 to 69 years) following posterolateral thoracotomy were randomly allocated to the therapeutic kinesio taping group (n=44) or the control group (n=33). Kinesio taping was applied to the kinesio taping group for seven days. Pain, respiratory functions, respiratory muscle strength, amount of analgesic drug use, and quality of life were evaluated preoperatively, on postoperative Day 0, before tape application, postoperative Days 1, 2, and 7, and at postoperative first month. Results There was no significant difference between the groups in terms of demographic and clinical characteristics. The results of respiratory functions and respiratory muscle strength were all improved in both groups, while there were more significant improvements in the kinesio taping group. There was a statistically significant difference in the mean Visual Analog Scale scores on postoperative Days 2 and 7 between the two groups. The amount of tramadol use of the patients in the kinesio taping group was significantly lower on postoperative Days 2 and 7 than in the control group. Conclusion Kinesio taping is an effective method to reduce pain and improve respiratory function after posterolateral thoracotomy. Therefore, it is thought that kinesio taping should be applied as a part of the pulmonary rehabilitation program after thoracotomy.
背景:本研究旨在探讨肌动贴对后外侧胸廓切开术后患者的疼痛、呼吸功能和呼吸肌力量的影响:本研究旨在探讨肌动贴对后外侧胸廓切开术后患者的疼痛、呼吸功能和呼吸肌力量的影响:方法:2019 年 6 月至 2020 年 5 月期间,将后外侧胸廓切开术后的 88 例患者(男 48 例,女 40 例;平均年龄:(56.1±9.0)岁;范围:28 至 69 岁)随机分配至治疗性肌腱贴组(n=44)或对照组(n=33)。肌动贴治疗组应用肌动贴七天。对术前、术后第 0 天、绑带前、术后第 1、2、7 天以及术后第一个月的疼痛、呼吸功能、呼吸肌力量、镇痛药物用量和生活质量进行评估:结果:两组在人口统计学和临床特征方面无明显差异。两组患者的呼吸功能和呼吸肌力量均有所改善,而肌张力贴敷组有更明显的改善。两组患者术后第 2 天和第 7 天的平均视觉模拟量表评分差异有统计学意义。在术后第 2 天和第 7 天,肌动绑扎组患者的曲马多用量明显低于对照组:结论:胸廓后外侧切开术后,肌动贴是减轻疼痛和改善呼吸功能的有效方法。结论:胸廓后外侧切开术后,运动绑带是减轻疼痛和改善呼吸功能的有效方法,因此,运动绑带应作为胸廓切开术后肺康复计划的一部分。
{"title":"The effect of kinesio taping on pain, respiratory function, and muscle strength after thoracotomy.","authors":"Neriman Temel Aksu, Mükerrem Erdoğan, Abdullah Erdoğan","doi":"10.5606/tgkdc.dergisi.2023.24407","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.24407","url":null,"abstract":"Background This study aims to investigate the effectiveness of kinesio taping on pain, respiratory function, and respiratory muscle strength in patients after posterolateral thoracotomy. Methods Between June 2019 and May 2020, a total of 88 patients (48 males, 40 females; mean age: 56.1±9.0 years; range, 28 to 69 years) following posterolateral thoracotomy were randomly allocated to the therapeutic kinesio taping group (n=44) or the control group (n=33). Kinesio taping was applied to the kinesio taping group for seven days. Pain, respiratory functions, respiratory muscle strength, amount of analgesic drug use, and quality of life were evaluated preoperatively, on postoperative Day 0, before tape application, postoperative Days 1, 2, and 7, and at postoperative first month. Results There was no significant difference between the groups in terms of demographic and clinical characteristics. The results of respiratory functions and respiratory muscle strength were all improved in both groups, while there were more significant improvements in the kinesio taping group. There was a statistically significant difference in the mean Visual Analog Scale scores on postoperative Days 2 and 7 between the two groups. The amount of tramadol use of the patients in the kinesio taping group was significantly lower on postoperative Days 2 and 7 than in the control group. Conclusion Kinesio taping is an effective method to reduce pain and improve respiratory function after posterolateral thoracotomy. Therefore, it is thought that kinesio taping should be applied as a part of the pulmonary rehabilitation program after thoracotomy.","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"507-516"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive multi-vessel coronary artery bypass grafting and concomitant mitral valve replacement via bilateral mini-thoracotomy: An alternative to sternotomy. 通过双侧小胸腔切口进行微创多血管冠状动脉旁路移植术并同时进行二尖瓣置换术:胸骨切开术的替代方案。
IF 0.6 4区 医学 Q4 SURGERY Pub Date : 2023-10-19 eCollection Date: 2023-10-01 DOI: 10.5606/tgkdc.dergisi.2023.23836
Barış Çaynak, Hüseyin Sicim

Minimally invasive methods continue to become increasingly common in cardiac surgery. In particular, the utilization of thoracotomy in multi-vessel coronary bypass grafting and valve surgery has accelerated, but sternotomy is still applied in combined pathologies. A 76-year-old male patient underwent multi-vessel coronary artery bypass grafting and mitral valve replacement without sternotomy using bilateral mini-thoracotomy, as the patient was old, frail, and had many comorbid factors. In conclusion, this minimally invasive approach can decrease all postoperative complications, accelerate patient recovery, and achieve good cosmetic results.

微创方法在心脏外科手术中越来越常见。尤其是在多支血管冠状动脉旁路移植术和瓣膜手术中,胸廓切开术的应用已经加速,但胸骨切开术仍适用于合并病变。一名 76 岁的男性患者因年老体弱、合并症多,在未进行胸骨切开术的情况下,使用双侧小胸腔切开术进行了多血管冠状动脉旁路移植术和二尖瓣置换术。总之,这种微创方法可以减少所有术后并发症,加快患者康复,并达到良好的美容效果。
{"title":"Minimally invasive multi-vessel coronary artery bypass grafting and concomitant mitral valve replacement via bilateral mini-thoracotomy: An alternative to sternotomy.","authors":"Barış Çaynak, Hüseyin Sicim","doi":"10.5606/tgkdc.dergisi.2023.23836","DOIUrl":"https://doi.org/10.5606/tgkdc.dergisi.2023.23836","url":null,"abstract":"<p><p>Minimally invasive methods continue to become increasingly common in cardiac surgery. In particular, the utilization of thoracotomy in multi-vessel coronary bypass grafting and valve surgery has accelerated, but sternotomy is still applied in combined pathologies. A 76-year-old male patient underwent multi-vessel coronary artery bypass grafting and mitral valve replacement without sternotomy using bilateral mini-thoracotomy, as the patient was old, frail, and had many comorbid factors. In conclusion, this minimally invasive approach can decrease all postoperative complications, accelerate patient recovery, and achieve good cosmetic results.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"31 4","pages":"573-576"},"PeriodicalIF":0.6,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1